Morningstar.co.uk contains data, news and research on stocks and funds, unique commentary and independent Morningstar research on a wide range of investment products, as well as portfolio and asset allocation tools to help you make better investment decisions.
MyHealthChecked PLC – Cardiff-based healthcare company focused on home health and wellness testing – signs contract with AAH Pharmaceuticals Ltd, known as Lloyds Pharmacy, to supply rapid Covid-19 antigen tests. The test can be carried out at home before departure and provides results within two hours. The test gives a passenger a certificate that is suitable for the outward or return journey. The test will be the only rapid antigen test for Covid-19 sold through Lloyds Pharmacy and launched in January.
(Alliance News) – Mercia Asset Management PLC announced on Wednesday that it has acquired a stake in …
(Alliance News) – ADF PLC facilities have their first day of trading on AIM on the London Sto …
(Alliance News) – Playtech PLC postponed a shareholders’ meeting on Wednesday to vote on a …
Mining companies are operating in a challenging environment, but now may be the time to …
It’s all changing at the top and bottom of investment trusts league tables as 2021 turns out to be …
As the cost of living rises and people feel the pressure, there is no better time to start over …
In this series, we survey leading fund managers on everything from their investment strategy to …
The Morningstar Star Rating for stocks is based on an analyst’s estimate of the fair value of a stock. It is a projection / opinion and not a statement of fact. Morningstar assigns star ratings based on an analyst’s estimate of the fair value of a stock. Four components determine the star rating: (1) our assessment of the company’s economic divide, (2) our estimate of the fair value of the share, (3) our uncertainty regarding this estimate of the fair value and (4) the current market price. This process culminates in a one-point star rating that is updated daily. A 5-star rating represents the belief that the stock has good value at its current price; it is not a 1-star share. If our assumptions are correct in the base case, then over time, generally within three years, the market price will approach our fair value estimate. Investments in securities are subject to market and other risks. Past performance of a security may or may not be maintained in the future and is not an indication of future performance. Detailed information on the Morningstar Star Rating for Stocks can be found here
The Quantitative Fair Value Estimate is Morningstar’s estimate of the dollar amount per share that a company’s equity is worth today. The quantitative fair value estimate is based on a statistical model derived from the fair value estimate that Morningstar’s equity analysts attribute to companies, which includes a financial forecast for the company. The quantitative fair value estimate is calculated daily. It is a projection / opinion and not a statement of fact. Investments in securities are subject to market and other risks. Past performance of a security may or may not be maintained in the future and is not an indication of future performance. You can find detailed information on the quantitative fair value estimate here
Keywords:
